Synvitrobio Inc

Abbott Diabetes Care, located in Alameda, Calif., designs, develops and manufactures several glucose monitoring systems and test strips for use in both home and hospital settings. Among its brands are FreeStyle, FreeStyle Flash, Precision Xtra and Precision PCx. Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In 2004, the company acquired TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results. ADC is a subsidiary of Abbott Laboratories, a global health care company devoted to the discovery of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.

Exelixis is an integrated drug discovery and development company. The company utilizes cutting-edge genomic, molecular biology and combinatorial chemistry technologies to develop innovative therapies for significant human diseases. Its primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease. Exelixis has built a research and discovery platform. The Exelixis clinical development pipeline includes compounds in cancer and renal disease. The company s pre-clinical pipeline is comprised of six programs. The pre-clinical oncology programs consist of development candidates that focus on inhibiting kinases. In its pre-clinical metabolic disease programs, Exelixis has developed small molecules that modulate nuclear hormone receptors that implicate various metabolic and cardiovascular disorders. Corporate headquarters are in San Francisco. The research facility is in Portland, Ore.

Rubedo Life Sciences, based in Oakland, CA, is a clinical-stage biotechnology company focused on discovering and developing medicines that target the pathological cells driving aging and chronic diseases, aiming to keep individuals biologically young and healthy. Founded by a group of leading scientists and entrepreneurs passionate about the science of aging, Rubedo seeks to innovate therapeutic solutions that enhance healthspan and longevity. The company's name, derived from a Latin word meaning "redness," symbolizes the alchemist's ultimate goal of creating a universal medicine for longevity and disease cure. With a robust pipeline and strategic partnerships, Rubedo Life Sciences is committed to pioneering advancements in the field of cellular aging and health improvement. Generated from the website